Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bulevirtide (1 trial)
pegylated-interferon (1 trial)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis, Chronic (Phase 2)
Hepatitis D (Phase 2)
Hepatitis D, Chronic (Phase 2)
Infections (Phase 2)
Trials (1 total)
Trial APIs (2 total)